Catalyst News and Research

RSS
Stand Up To Cancer announces $1.1 million in funding to foster collaborative research

Stand Up To Cancer announces $1.1 million in funding to foster collaborative research

Waterloo tech profiles antibodies in blood of COVID-19 patients

Waterloo tech profiles antibodies in blood of COVID-19 patients

Simple blood test may be a great advance for people with and at risk for Alzheimer's

Simple blood test may be a great advance for people with and at risk for Alzheimer's

Study: Cobalt-doped titanium-dioxide stops the reproduction of listeria monocytogenes

Study: Cobalt-doped titanium-dioxide stops the reproduction of listeria monocytogenes

Brigham to play two key roles in phase 3 trial of COVID-19 vaccine candidate

Brigham to play two key roles in phase 3 trial of COVID-19 vaccine candidate

Pandemic to accelerate the adoption of technology-enabled care for epilepsy

Pandemic to accelerate the adoption of technology-enabled care for epilepsy

Age-related hearing loss mainly caused by damage to hair cells, study shows

Age-related hearing loss mainly caused by damage to hair cells, study shows

Stand Up To Cancer announces new effort to achieve health equity for underserved lung cancer patients

Stand Up To Cancer announces new effort to achieve health equity for underserved lung cancer patients

MUSC chosen to build prototype for increasing ICU surge capacity during COVID-19

MUSC chosen to build prototype for increasing ICU surge capacity during COVID-19

Rice engineers find efficient catalyst for destroying PFAS 'forever' chemicals

Rice engineers find efficient catalyst for destroying PFAS 'forever' chemicals

Researchers use nanoparticles to deliver gene therapy for blinding eye disease

Researchers use nanoparticles to deliver gene therapy for blinding eye disease

Cannabis offences in schools across England rise, data reveals

Cannabis offences in schools across England rise, data reveals

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

Scientists design chiral ligands to generate useful compounds

Scientists design chiral ligands to generate useful compounds

A novel strategy to achieve site-selective chiral drug synthesis in living systems

A novel strategy to achieve site-selective chiral drug synthesis in living systems

Ghost bill: UVA siphons couple’s tax refund to pay 20-year-old medical debt

Ghost bill: UVA siphons couple’s tax refund to pay 20-year-old medical debt

New virtual incubator can catalyze early-stage drug discovery and development

New virtual incubator can catalyze early-stage drug discovery and development

Affordable and easy-to-use emergency ventilator developed for COVID-19 patients

Affordable and easy-to-use emergency ventilator developed for COVID-19 patients

Multidisciplinary pediatric aerodigestive centers provide better outcomes with reduced costs

Multidisciplinary pediatric aerodigestive centers provide better outcomes with reduced costs

BIA Separations launches novel PrimaS ligand technology to facilitate development of advanced therapies

BIA Separations launches novel PrimaS ligand technology to facilitate development of advanced therapies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.